title: Emergency department presentation of heart transplant recipients with acute heart failure.
abstract: With an increasing number of heart transplants being performed around the world and the improvement in survival rates, more transplant recipients may present to the emergency department with comorbidities unique to the transplanted heart and related immunosuppression, including heart failure. This article is aimed at enabling the emergency department physician identify and better manage this unique group of patients for whom time is life.
authors.affiliation: Division of Hospital Medicine, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, OH 43210, USA. paul.chacko@osumc.edu
authors.forename: Paul
authors.initials: P
authors.lastname: Chacko
authors.forename: Shibu
authors.initials: S
authors.lastname: Philip
mesh_terms: D001145:Arrhythmias, Cardiac / Q000150:complications; D000075202:Contraindications; D003324:Coronary Artery Disease / Q000150:complications; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000175:diagnosis; D004562:Electrocardiography; D004636:Emergency Service, Hospital; D006333:Heart Failure / Q000628:therapy*; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D009206:Myocardium / Q000473:pathology; D045265:Natriuretic Peptides / Q000097:blood; D011183:Postoperative Complications / Q000175:diagnosis; D014184:Transplantation, Homologous; D018487:Ventricular Dysfunction, Left / Q000209:etiology
chemical_list: D007166:Immunosuppressive Agents; D045265:Natriuretic Peptides; D009173:Mycophenolic Acid